# Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: A multinational, randomized, open-label, two-period, crossover noninferiority trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tolerability-and-efficacy-of-exenatide-and-titrated-insulin-glargine-in-adult/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Anthony Barnett,Jude Burger,Don Johns,Robert G. Brodows,David M. Kendall,Anthony Roberts,Michael Trautmann |
| Citations | 240 |
| DOI | 10.1016/j.clinthera.2007.11.006 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1976287166 |
| PMID | 18158075 |
| Type | article |
| Year | 2007 |

## Paper authors

- [David M. Kendall](https://scholariq.org/researchers/david-m-kendall/)

## Paper journal

- [Clinical Therapeutics](https://scholariq.org/journals/clinical-therapeutics/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.